Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

240
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
240
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Longitudinal Studies01:26

Longitudinal Studies

473
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
473
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

497
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
497
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

246
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
246

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Erythrocyte Count, Anemia, and the Human Natural Lifespan Limit: Evidence from the Long Life Family Study.

bioRxiv : the preprint server for biology·2026
Same author

Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease.

Statistics in medicine·2026
Same author

Deep learning for the joint analysis of item-level longitudinal and survival data.

Journal of applied statistics·2026
Same author

Exploration of Optimal Synergistic Treatment Strategies of Postoperative Radiotherapy and Immunotherapy in Early-Stage Breast Cancer.

Cancers·2026
Same author

Joint modeling of high-dimensional longitudinal data and survival using supervised low-rank tensor decomposition.

Biostatistics (Oxford, England)·2026
Same author

Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment.

Cancers·2026

相关实验视频

Updated: Jan 14, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

动态预测使用功能潜伏特征关节模型用于多变量纵向结果:对帕金森病的应用.

Mohammad Samsul Alam1, Dongrak Choi1, Salil Koner1

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Statistics in medicine
|October 17, 2025
PubMed
概括

这项研究引入了一个新的模型 (FLTM-JM) 来分析复杂的帕金森病 (PD) 数据,整合症状进展和生存结果,以获得更好的患者洞察力和个性化治疗策略.

关键词:
贝叶斯的推理 贝叶斯的推理疾病的进展 疾病的进展功能数据分析数据分析.个性化医疗是个性化的医疗.生存分析,生存分析.

更多相关视频

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

相关实验视频

Last Updated: Jan 14, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

科学领域:

  • 生物统计学 生物统计学
  • 临床信息学 临床信息学
  • 神经科学是一个神经科学.

背景情况:

  • 帕金森病 (PD) 是渐进性的,需要对各种纵向数据类型进行分析.
  • 了解症状进展和生存结果需要先进的统计方法.
  • 目前的方法可能无法完全捕捉PD中多变量纵向和时间到事件数据的复杂性.

研究的目的:

  • 引入功能潜伏特征模型-联合模型 (FLTM-JM) 来共同分析多变量纵向数据和PD生存结果.
  • 为了提供一个灵活的框架来建模随时间推移的复杂共变量关系.
  • 为了实现针对个性化治疗策略的动态,特定对象的预测.

主要方法:

  • 开发了一种基于功能潜伏特征模型 (FLTM) 的新型联合建模框架 (FLTM-JM).
  • 使用非参数,函数对标尺回归用于纵向数据的灵活建模.
  • 将模型应用于来自帕金森病进展标记计划 (PPMI) 的运动障碍学会统一帕金森病评级表 (MDS-UPDRS) 数据.

主要成果:

  • FLTM-JM有效地整合了多变量纵向数据和时间到事件结果.
  • 该模型确定了对PD进展的关键共变量影响.
  • 证明了动态,主体特定预测对临床决策的有用性.
  • 模拟研究证实了准确性,稳定性和效率,即使在模型的错误规格.

结论:

  • FLTM-JM为分析复杂的PD数据提供了一种强大的方法.
  • 该框架通过提供动态预测来支持个性化医疗.
  • 这种方法提高了对疾病发展轨迹的理解,并为临床管理提供了信息.